Apellis Pharmaceuticals: Q1 Earnings Insights

Apellis Pharmaceuticals APLS reported its Q1 earnings results on Thursday, May 4, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

Apellis Pharmaceuticals missed estimated earnings by 6.85%, reporting an EPS of $-1.56 versus an estimate of $-1.46.

Revenue was up $30.46 million from the same period last year.

Last quarter the company beat on EPS by $0.07 which was followed by a 12.51% increase in the share price the next day.

Here's a look at Apellis Pharmaceuticals's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	-1.57	-1.45	-1.36	-1.32
EPS Actual	-1.50	-1.75	-1.46	-1.42
Revenue Estimate	24.19M	21.59M	16.94M	12.57M
Revenue Actual	22.66M	22.06M	16.32M	14.38M

To track all earnings releases for Apellis Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar